Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block-Reference-Cited by-同舟云学术

Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block

Published:2020-02-13 Issue:4 Volume:20 Page:421-427
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Fiorino Gionata¹²,Allocca Mariangela¹²,Correale Carmen¹,Roda Giulia¹,Furfaro Federica¹,Loy Laura¹,Zilli Alessandra¹,Peyrin-Biroulet Laurent³,Danese Silvio¹²^ORCID

Affiliation:

1. IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Institute, Milan, Italy

2. Department of Biomedical Sciences, Humanitas University, Milan, Italy

3. Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1727437

Reference37 articles.

1. Crohn's disease

2. Ulcerative Colitis

3. Innate and adaptive immunity in inflammatory bowel disease

4. Cytokines in inflammatory bowel disease

5. Biological Agents for Moderately to Severely Active Ulcerative Colitis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

2. Identification of potential crucial genes shared in psoriasis and ulcerative colitis by machine learning and integrated bioinformatics;Skin Research and Technology;2024-02

3. Ustekinumab as a Treatment for Ixekizumab-Associated New-Onset Crohn's Disease in a Patient with Psoriasis;ACG Case Reports Journal;2024-01-31

4. Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases;Journal of Clinical Medicine;2023-05-04

5. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout;Immunological Investigations;2023-02-06